Sponsored Content | Case Study | Cardiovascular Business | December 13, 2016 | By Praveen Lobo, Vice President Strategic Products – LUMEDX Corporation

Improving the Business Performance of Heart and Vascular Centers

An effective data strategy facilitates improved business outcomes

cardiovascular data intelligence

New operational realities demand new ways of measuring the qualitative value of clinical procedures.


The primary goal of any healthcare provider is to improve the lives of patients through effective treatment. However, because they are also businesses, hospitals have concerns that entail much more than this. To be viable in the long term, hospitals must manage their margins to fund their mission.

There are three main pillars of business concern for any hospital:

  • Clinical — health outcomes are measured with the goal of healthier patients leaving the facility.
  • Financial — the dollars must add up to keep the enterprise solvent.
  • Operational — staffing and facilities are measured against cost and need.

Ultimate success for a hospital demands focused attention on all three areas. It's incumbent upon clinicians and service line managers to work together to seek out efficiencies in each of them. 

New Operational Realities

Payers' shift away from a fee-for-service model toward a value-based payment model demands that clinicians and administrators expand the above-mentioned pillars to include cost, patient outcomes, and patient satisfaction.

These changes aren’t easy. Providers have long been paid based on quantitative measures: the number of procedures performed. New operational realities demand new ways of measuring the qualitative value of those procedures. Reimbursement is linked to these metrics, and hospitals must find ways to leverage their investments in data technology in order to maximize their financial opportunities.

Granular Data Brings Actionable Insights

Data is critical to the shift to VBP. For example, for CABG procedures, if we know that extubation under 24 hours after surgery improves patient outcomes, it makes sense to monitor that metric internally on an ongoing basis. When outliers crop up, data points gathered from across the treatment spectrum can allow us to understand why. Perhaps a different treatment was needed at the outset, or some other patient health factor influenced that measure.

Over time, granular data can allow us to understand which type of treatment is best for patient outcomes in that circumstance.

It is discrete, granular data that can help providers fine-tune their processes in order to improve patient outcomes — and of course patient satisfaction. This same kind of close analysis can be applied to reducing costs. But for all three new, expanded pillars, efficient data collection, management, and analysis are needed. 

LUMEDX offers cardiovascular data intelligence: technologies that collect more than 30,000 discrete data points—from point-of-care devices to physician reporting. This rich data set enables meaningful insights in the areas of treatment options, clinical evaluation and training, and service line optimization.

Watch the VIDEO “Lumedx Cardiovascular Performance Program: A New Approach to Managing Quality and Cost.”

For more information, visit www.lumedx.com


Related Content

News | Cardiovascular Business

April 9, 2024 — Cathie Biga, MSN, FACC, today became president of the American College of Cardiology and made history as ...

Home April 09, 2024
Home
News | Cardiovascular Business

April 5, 2024 — The Cardiovascular Research Foundation (CRF) has announced New York Valves: The Structural Heart Summit ...

Home April 05, 2024
Home
News | Cardiovascular Business

April 5, 2024 — Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive ...

Home April 05, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Here is a Top 10 look at the content that was trending during the month of March on dicardiology.com: 1. CLS Health ...

Home April 04, 2024
Home
News | Cardiovascular Business

March 19, 2024 — The American College of Cardiology (ACC) has selected 50 learners for its 2024 – 2025 Clinical Trials ...

Home March 19, 2024
Home
News | Cardiovascular Business

March 19, 2024 — Titan Medical Inc. announced that it has entered into a definitive amalgamation agreement (the ...

Home March 19, 2024
Home
News | Cardiovascular Business

March 15, 2024 —Renowned cardiovascular surgeon Gilbert H. L. Tang, MD, has been named Editor-in-Chief of JACC: Case ...

Home March 15, 2024
Home
News | Cardiovascular Business

March 15, 2024 —Renowned cardiovascular surgeon Gilbert H. L. Tang, MD, has been named Editor-in-Chief of JACC: Case ...

Home March 15, 2024
Home
News | Cardiovascular Business

March 13, 2024 — Two nationally recognized cardiovascular programs, New Jersey-based Atlantic Health System’s Morristown ...

Home March 13, 2024
Home
News | Cardiovascular Business

March 11, 2024 — VahatiCor, Inc., a med tech company dedicated to helping patients with persistent ischemic heart ...

Home March 11, 2024
Home
Subscribe Now